slider placeholder Continuing a legacy
built upon trust

Pairing outstanding talent with expertise

Surgimon pioneered the development of neuromonitoring to reduce patient risk during surgery. Today, neuromonitoring is widely adopted. Our experience spans every type of surgical facility and applicable procedure. Our reputation is defined by our exceptional people. Working with surgeons, hospitals, and patients across the country, we continue to develop effective, quality neuromonitoring solutions.

How we measure our success

Performance in healthcare is measured by patient outcomes and hospital efficiency. At Surgimon, we believe that relentless aspiration for performance improvement defines our ability to make a difference. We evaluate our contribution to hospital efficiency by surgeon satisfaction, operating room time reduction, and cost savings. But above all else is patient safety, which is why Surgimon sustains its quality assurance plan in accordance with its accreditation by the The Joint Commission.

Surgimon Joint Commission Accredited


Gary Schurman, AuD, D-ABNM, President and Founder


Dr. Schurman began his career in audiology and neuromonitoring over 35 years ago. He is a leader and innovator in the field. He has authored several scientific articles and textbook chapters. In addition to his clinical responsibilities, he has maintained an active teaching schedule of neurosurgery and orthopedic residents. He is a Diplomate of the American Board of Neurophysiologic Monitoring.


Dr. Schurman received his bachelor and master degrees from the University of Pittsburgh, and later, his doctorate from the University of Florida.

John Ney, MD, Medical Director


Dr. Ney is a board-certified neurologist and clinical neurophysiologist with research interests in comparative effectiveness, outcomes research, and health economics. He is involved with active clinical trials which utilize patient-reported metrics and has published economic decision models, systematic reviews and meta-analyses, as well as results of multi-year analyses of real-world outcomes for health technology assessment in peer-reviewed MEDLINE-indexed publications. His clinical interests include peripheral neuropathy, neuropathic pain, neuromuscular diseases, and application of neuro-electrophysiology in the intensive care unit and the operating room.


Dr. Ney After completing undergraduate education at the University of Virginia. He earned an M.D. from Tulane.  His graduate medical training was performed at the Walter Reed Army Medical Center and National Naval Medical Center, where he completed internship and residency in Neurology, and a fellowship in Clinical Neurophysiology in 2005. He served as the Chief of Clinical Neurophysiology at Madigan Army Medical Center from 2005 to 2009, supervising electrophysiology technicians, performing and interpreting nerve conductions, electromyograms, electroencephalograms, and evoked potentials. He also earned an M.P.H from the University of Washington.


He served as a battalion surgeon for 1st battalion, 506th Infantry regiment, 101st Airborne for nine months in Afghanistan in 2008, and was awarded the Combat Medical Badge and Bronze Star in 2009.

Chris Schurman, Chief Executive Officer


Chris Schurman is Chief Executive Officer for Surgimon, a role he has held since June 2018. He has more than 15 years of clinical, consulting, and management experience and has been with the company since 2007. He served as Vice President of Surgimon from 2012 to 2018. Prior to that, Chris served as a neuromonitoring technologist at the company.


Before joining Surgimon, Chris was part of the team promoting and implementing open auction-based IPO offerings at WR Hambrecht + Co. Chris previously worked on local and state government strategic consulting projects while at CGI.


Chris received his bachelor’s degree from the University of Pennsylvania.